Federal Circuit Grants Rehearing, Declares Novartis Patent Invalid
WASHINGTON, D.C. — In a June 21 holding, a divided Federal Circuit U.S. Court of Appeals said a Delaware federal judge’s finding that a “no-loading-dose” limitation in a patented multiple treatment...To view the full article, register now.
Already a subscriber? Click here to view full article